Alzheimeŕs Disease Research Center, NCS, Karolinska Institute, Stockholm, Sweden.
Int J Geriatr Psychiatry. 2011 Aug;26(8):825-32. doi: 10.1002/gps.2610. Epub 2010 Oct 28.
Care for demented people is very resource demanding, the prevalence is increasing and there is so far no cure. Cost of illness (CoI) studies are important by identifying the distribution of costs between different payers of care. The European Union (EU) funded the European Collaboration on Dementia (Eurocode) as part of the EU's 2005 work plan of the Community public health programme. Eurocode was administered by Alzheimer Europe. The aim was to describe the economic impact of dementia in Europe in 2008.
Eurocode's new estimates for dementia prevalence were included in a cost model based on published European CoI papers. For countries where no CoI figures were available, imputation was used.
The total CoI of dementia in the EU27 in 2008 was estimated to be €160 billion (€22 000 per demented per year), of which 56% were costs of informal care. The corresponding costs for the whole Europe was €177 billion. In northern Europe, the direct costs are estimated to be considerabe, while the cost of informal care is the major cost component in southern Europe. The sensitivity analysis showed a range for total EU27 costs between €111 and 168 billion.
The estimated CoI in this study is higher than in previous studies. There are also large differences in different European regions. Notwithstanding the methodological challenges, the societal costs of dementia in Europe are very high which in turn have substantial resource impacts on the social and health care systems in Europe.
照顾痴呆患者需要大量资源，其患病率正在上升，目前尚无治愈方法。疾病成本（CoI）研究通过确定不同护理支付者之间的成本分配很重要。欧盟（EU）资助了欧洲痴呆症合作研究（Eurocode），作为欧盟 2005 年社区公共卫生计划的一部分。Eurocode 由阿尔茨海默病欧洲协会管理。目的是描述 2008 年欧洲痴呆症的经济影响。
将 Eurocode 对痴呆症患病率的新估计纳入基于已发表的欧洲 CoI 论文的成本模型中。对于没有 CoI 数据的国家，使用了估算。
2008 年欧盟 27 国痴呆症的总 CoI 估计为 1600 亿欧元（每位痴呆症患者每年 22000 欧元），其中 56%是非正式护理的成本。整个欧洲的相应成本为 1770 亿欧元。在北欧，直接成本估计相当大，而在南欧，非正式护理成本是主要的成本组成部分。敏感性分析显示，欧盟 27 国总费用的范围在 1110 亿至 1680 亿欧元之间。
本研究中的估计 CoI 高于以前的研究。不同的欧洲地区也存在很大差异。尽管存在方法学挑战，但欧洲痴呆症的社会成本非常高，这反过来对欧洲的社会和卫生保健系统产生了重大的资源影响。
